IFP Advisors’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

IFP Advisors’s Portfolio ALXA Stock Details ALXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-400	Closed	–	–	4208
2015 Q4	$0	Buy	+400	New	+$413	﹤0.01%	3884

Other funds holding ALXA

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $8.13B AUM 26.03% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

IFP Advisors's ALXA Position: Q1 2016 in Review

IFP Advisors sold out of Alexza Pharmaceuticals Inc (ALXA) in Q1 2016, closing a stake of 400 shares.

IFP Advisors first reported a position in ALXA in Q4 2015 and held it in 1 quarter. The position peaked at $0 in Q4 2015. 25 funds tracked by Wall St. Rank hold ALXA as of Q1 2016.

IFP Advisors reported no remaining Alexza Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
IFP Advisors sold 400 Alexza Pharmaceuticals Inc shares in Q1 2016.
IFP Advisors first reported a position in Alexza Pharmaceuticals Inc in Q4 2015 and held it in 1 quarter.
IFP Advisors's Alexza Pharmaceuticals Inc position peaked at $0 in Q4 2015.
25 funds tracked by Wall St. Rank held Alexza Pharmaceuticals Inc as of Q1 2016.

Based on IFP Advisors's 13F filing for Q1 2016, filed 2 May 2016.